A. Mateo-Alonso, M. Prato
FULL PAPER
123–125 °C. H NMR (CDCl3): δ = 8.13 (t, J = 1.4 Hz, 1 H, Ar),
1
1733.7, 1623.3, 1522.6, 1452.1, 1424.2, 1322.0, 1264.1, 1123.3,
7.77 (d, J = 1.4 Hz, 2 H, Ar), 7.08 (br. s, 1 H, OH), 1.59 (s, 18 H, 1091.0, 1021.6, 819.1, 756.9, 700.0 cm–1. UV/Vis (THF): λmax
=
tBu) ppm. 13C NMR (CDCl3): δ = 165.25, 159.21, 133.25, 122.44,
120.44, 82.00, 28.15 ppm. MS (ES): calcd. for C16H22O5 [M]+
294.3; found 294.9.
255, 317, 431, 704 nm.
Rotaxane 9: A solution of p-xylylenediamine (251 mg, 1.842 mmol)
in chloroform (anhydrous, stabilised with amylenes, 40 mL) con-
taining NEt3 (0.27 mL, 3.684 mmol) and a separate solution of 5
(761 mg, 1.842 mmol) in chloroform (anhydrous, stabilised with
amylenes, 40 mL) were added simultaneously over 4 h to a stirred
solution of thread 8 (169 mg, 0.147 mmol) in CHCl3 (anhydrous,
stabilised with amylenes, 25 mL) under argon. After the addition,
the reaction mixture was stirred for an additional 90 min at room
temperature. The solution was filtered through Celite and concen-
trated to dryness. Rotaxane 9 (70 mg, 22%) was separated from
the unreacted thread 6 by chromatography (CHCl3/MeOH, 99:1)
followed by reprecipitation (DCM/petroleum ether, ϫ3). 1H NMR
(CHCl3): δ = 8.37 (s, 2 H, a), 8.07 (s, 4 H, b), 7.48–7.46 (m, 4 H,
c), 7.40–7.10 (m, 10 H, A), 6.98 (s, 8 H, d), 6.67–6.59 (m, 1 H, B),
5.77–5.71 (m, 1 H, C), 5.01–4.98 (m, 4 H, e), 4.67–4.58 (m, 4 H,
g), 4.56–4.53 (m, 4 H, f), 4.53 (s, 1 H, D), 4.44 (s, 4 H, E), 4.36 (s,
10 H, i), 4.31–4.23 (m, 4 H, g), 3.98–3.93 (m, 2 H, F), 3.83–3.80
(m, 2 H, I), 3.74–3.68 (m, 2 H, I), 3.53–3.48 (m, 2 H, J), 3.38–3.19
(m, 4 H, L + K), 2.75–2.71 (m, 2 H, G) ppm. 13C NMR (CHCl3):
δ = 170.32, 168.98, 165.39, 145.77, 151.75, 147.19, 146.13, 145.95,
145.51, 145.27, 145.18, 144.42, 142.98, 142.53, 142.04, 141.95,
141.76, 140.01, 136.41, 137.32, 136.03, 135.71, 129.01, 126.87,
128.40, 127.86, 125.20, 121.06, 72.27, 70.74, 70.12, 69.30, 68.71,
68.24, 58.33, 54.09, 44.06 ppm. MS (ES): calcd. for
tert-Butyl 5-Ferroceneacetoxyisophthalate (3): EDC (1.360 g,
6.88 mmol) was added in small portions to a solution of compound
2 (2.026 g, 6.88 mmol), ferroceneacetic acid (1.583 g, 6.88 mmol)
and DMAP (0.840 g, 6.88 mmol) in DCM (160 mL). The solution
was stirred at room temperature for 24 h. Then the solution was
taken up in AcOEt and washed with aqueous HCl (3.5%, 2ϫ),
aqueous NaHCO3 (50% water-diluted saturated solution, 2ϫ) and
brine (1ϫ). The organic phase was dried with MgSO4 and the
solvent was evaporated to give the title compound (3.256 g, 93%);
1
m.p. 142–144 °C. H NMR (CDCl3): δ = 8.47 (t, J = 1.5 Hz, 1 H,
Ar), 7.92 (d, J = 1.5 Hz, 2 H, Ar), 4.95 (t, J = 1.8 Hz, 2 H, Fc),
4.52 (t, J = 1.8 Hz, 2 H, Fc), 4.32 (s, 5 H, Fc), 1.60 (s, 18 H,
tBu) ppm. 13C NMR (CDCl3): δ = 164.09, 150.65, 133.53, 127.52,
126.66, 81.92, 72.16, 70.65, 70.01, 28.13 ppm. MS (ES): calcd. for
C27H30FeNaO6 [M + Na]+ 529.1; found 529.0.
5-Ferroceneacetoxyisophthalic Acid (4): Trifluoroacetic acid
(25 mL) was added to a solution of 3 (4.210 g, mmol) in DCM
(200 mL). The resulting solution was stirred at room temperature
for 24 h. Evaporation of the solvent under vacuum gave the title
compound in a quantitative yield; m.p. 210 °C (decomposition). 1H
NMR (CD3OD): δ = 8.56 (t, J = 1.5 Hz, Ar), 8.01 (d, J = 1.5 Hz,
2 H, Ar), 5.00 (br. t, 2 H, Fc), 4.63 (br. t, 2 H, Fc), 4.36 (s, 5 H,
Fc) ppm. 13C NMR (CD3O3): δ = 177.85, 167.76, 152.35, 133.97,
128.86, 128.09, 73.65, 71.78, 71.17 ppm. MS (ES): calcd. for
C19H14FeNaO6 [M + Na]+ 417.0; found 417.1.
C
138H76Fe2N7O12 [M + H]+ 2135.4; found 2135.3. IR: ν = 2930.3,
˜
2854.1, 1728.9, 1644.0, 1603.5, 1581.3, 1513.8, 1462.7, 1376.9,
1264.1, 1123.3, 1089.6, 1021.1, 893.8, 821.5, 741.5, 704.8 cm–1. UV/
Vis (THF): λmax = 256, 303, 325, 431, 705 nm.
Thread 12: Compound 10[53] (1.36 g, 1.25 mmol) was stirred in a
mixture of trifluoroacetic acid (20 mL) and DCM (20 mL) for 22 h.
The solvent was evaporated under vacuum. EDC (0.272 g,
1.37 mmol), 11[44] (0.336 g, 1.25 mmol) and HOBt (0.185 g,
1.370 mol) were added to a solution of the residue in chloroform
(anhydrous, stabilised with amylenes, 50 mL) under argon. The
solution was stirred at room temp. for 10 min. Then NEt3 (3 mL)
was added and the solution was stirred under argon for 18 h. The
solvent was evaporated and the residue was subjected to
chromatography (CHCl3/MeOH, 99:1) to obtain the title com-
5-Ferroceneacetoxyisophthaloyl Chloride (5): Oxalyl chloride (5 mL)
was slowly added to a dispersion of 4 (500 mg, mmol) in hexane
(50 mL) in the presence of DMF (0.1 mL). The dispersion was
stirred overnight under argon and turned into a red solution. The
solution was filtered through cotton and the solvent was evapo-
rated under vacuum to yield the title compound (500 mg, 94%),
1
which was used immediately after preparation. H NMR (CDCl3):
δ = 8.74 (t, J = 1.6 Hz, 1 H, Ar), 8.23 (d, J = 1.6 Hz, 2 H, Ar),
4.98 (t, J = 1.7 Hz, 2 H, Fc), 4.57 (t, J = 1.7 Hz, 2 H, Fc), 4.33 (s,
5 H, Fc) ppm.
1
pound (146 mg, 10%). H NMR (CHCl3): δ = 8.67 (br. s, 2 H, A),
Rotaxane 7: A solution of p-xylylenediamine (176 mg, 1.290 mmol)
in chloroform (anhydrous, stabilised with amylenes, 40 mL) and a
separate solution of 5 (556 mg, 1.290 mmol) in chloroform (anhy-
drous, stabilised with amylenes, 40 mL) were added simultaneously
over 4 h to a stirred solution of thread 6[32] (176 mg, 0.145 mmol)
in CHCl3 (anhydrous, stabilised with amylenes, 70 mL) containing
NEt3 (0.4 mL, 2.573 mmol) under argon. After the addition, the
reaction mixture was stirred overnight at room temperature. The
solution was filtered through Celite and concentrated to dryness.
Rotaxane 7 (37 mg, 12%) was separated from the unreacted thread
6 by chromatography (DCM/CHCl3, 1:2) followed by reprecipi-
tation (CHCl3/diethyl ether, ϫ3). 1H NMR (CDCl3): δ = 8.30 (s, 2
H, a), 7.96 (s, 4 H, b), 7.74 (br. s, 2 H, c), 7.70 (br. s, 2 H, c), 7.31–
7.16 (m, 12 H, A + C + D), 6.97 (s, 8 H, d), 5.77 (d, J = 15 Hz, 1
H, B), 5.67 (d, J = 15 Hz, 1 H, B), 5.00 (t, J = 2 Hz, 8 H, e), 4.87
(d, J = 10 Hz, 1 H, E), 4.53 (t, J = 2 Hz, 8 H, f), 4.45 (br. s, 8 H,
g), 4.34 (s, 10 H, i), 4.25–4.19 (m, 3 H, F + G + E), 3.90–3.59 (m,
5 H, I + J + K), 3.26–3.14 (m, 1 H, L), 2.57–2.49 (m, 1 H, M),
2.39–2.27 (m, 1 H, N), 1.90–1.78 (m, 2 H, O), 1.48–1.36 (m, 2 H,
P), 1.35–1.11 (m, 10 H, alkyl), 0.82 (t, J = 7 Hz, 3 H, CH3) ppm.
7.77 (br. s, 2 H, B), 7.36–7.22 (m, 10 H, C), 6.57 (t, J = 5 Hz, 1 H,
D), 6.54 (t, J = 5 Hz, 1 H, D), 5.19 (d, J = 10 Hz, 1 H, F), 5.17 (s,
1 H, G), 4.96 (s, 1 H, I), 4.30 (d, 1 H, J = 10 Hz, J), 4.05–3.95 (m,
2 H, K), 3.93 (d, J = 5 Hz, 2 H, L), 3.74–3.68 (m, 4 H, M), 3.57
(t, J = 5 Hz, 2 H, N), 3.34 (c, J = 5 Hz, 2 H, O), 3.38–3.32 (m, 1
H, P), 2.93–2.87 (m, 1 H, Q) ppm. 13C NMR (CHCl3): δ = 172.26,
168.38, 155.73, 153.54, 152.28, 151.90, 147.24, 147.21, 146.20,
146.11, 146.08, 146.06, 146.01, 145.87, 145.85, 154.51, 145.43,
145.40, 145.36, 145.27, 145.21, 145.17, 145.11, 145.09, 145.60,
144.42, 144.31, 144.21, 143.07, 142.93, 142.62, 142.52, 142.50,
142.46, 142.09, 142.06, 142.05, 142.00, 141.97, 141.91, 141.84,
141.72, 141.66, 141.59, 141.46, 140.15, 140.12, 139.84, 139.41,
138.96, 136.95, 136.19, 135.97, 135.42, 128.75, 128.72, 128.66,
128.45, 127.28, 127.15, 81.00, 74.42, 70.48, 70.40, 70.14, 69.63,
69.18, 67.59, 58.71, 52.18, 43.37, 39.33 ppm. MS (ES): calcd. for
C89H34N4O4 [M]+ 1222.2; found 1222.2. IR (NaCl): ν = 3302.5,
˜
3057.6, 2920.7, 1653.7, 1597.7, 1540.8, 1492.6, 1450.21, 1415.5,
1354.7, 1263.1, 1177.3, 1119.5, 1031.73, 828.3, 734.7, 700.0 cm–1.
UV/Vis (DCM): λmax = 256, 309, 325, 430, 703 nm.
MS (MALDI-TOF): calcd. for C146H93Fe2N7O10 [M + H]+ Rotaxane 13:
2217.03; found 2217.2. IR (NaCl): ν = 3275.0, 2921.6, 2851.7, 1.499 mmol) in chloroform (anhydrous, stabilised with amylenes,
A
solution of p-xylylenediamine (204 mg,
˜
1330
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 1324–1332